Omeprazol Viatris (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Viatris, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid secretion and is used to treat acid‑related disorders such as gastro‑oesophageal reflux disease, peptic ulcers and Zollinger‑Ellison syndrome in adult patients. GNH USA supplies Omeprazol Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway, providing relief in several acid‑related conditions. - Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and promotes healing of esophageal irritation. - Peptic ulcer disease: facilitates ulcer healing and prevents recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid production. - Erosive esophagitis: restores mucosal integrity and reduces inflammation.

Common Side Effects: - Headache: mild to moderate pain often occurring shortly after initiation. - Abdominal pain: discomfort or cramping in the stomach region. - Diarrhoea: loose, watery stools that may be transient. - Nausea: feeling of sickness or urge to vomit. - Flatulence: excess gas causing bloating. - Constipation: difficulty passing stools.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with rash, swelling and breathing difficulty. - Clostridioides difficile infection: severe colitis presenting with watery diarrhoea. - Hypomagnesemia: low magnesium levels causing muscle cramps or arrhythmia. - Hepatic enzyme elevation: increased liver function tests indicating possible liver stress. - Stevens‑Johnson syndrome: serious skin reaction with blistering and detachment. - Interstitial nephritis: kidney inflammation presenting with reduced urine output.

Before prescribing Omeprazol Viatris, consider the following precautions: - Renal function assessment: adjust use in patients with severe renal impairment. - CYP2C19 inhibitors: avoid concomitant use unless clinically required. - Infection monitoring: watch for signs of gastrointestinal infections, especially C. difficile. - Osteoporosis risk: use with caution in patients with reduced bone density. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Omeprazol Viatris may interact with several medicines; awareness of the interaction level helps manage risk. Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effectiveness. - Atazanavir: decreased antiviral absorption. - Methotrexate: increased toxicity due to reduced clearance. Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR and bleeding risk. - Diazepam: elevated plasma concentrations leading to sedation. - Digoxin: potential rise in serum levels requiring dose adjustment.